[Apoptosis and gamma rays]

Area of Science:

• Radiation biology
• Cellular and molecular biology
• Immunology

Background:

• Gamma radiation exposure can trigger programmed cell death (apoptosis) in lymphocytes.
• Apoptosis involves distinct morphological, biochemical, and molecular changes.
• Radioprotective agents, particularly those with antioxidant capabilities, may mitigate radiation-induced cellular damage.

Purpose of the Study:

• To explore the mechanisms of gamma radiation-induced lymphocyte apoptosis.
• To investigate the role of radioprotectors in modulating apoptosis.
• To examine the involvement of key regulatory proteins (p53, Fas, Bcl-2) in radiation injury and subsequent cell regeneration.

Main Methods:

• Analysis of radiation-induced morphological and biochemical modifications in lymphocytes.
• Measurement of DNA fragmentation and caspase activation.
• Assessment of phosphatidylserine externalization.
• Evaluation of the expression and function of p53, Fas, and Bcl-2 proteins.

Main Results:

• Gamma radiation demonstrably induces apoptosis in lymphocytes.
• Radioprotectors effectively inhibit radiation-induced DNA fragmentation and caspase activation.
• Key regulatory proteins p53, Fas, and Bcl-2 play significant roles in the apoptotic pathway.
• Pharmacological modulation of cell death pathways influences cell regeneration post-radiation.

Conclusions:

• Lymphocyte apoptosis is a critical response to gamma radiation.
• Antioxidant radioprotectors offer a promising approach to protect lymphocytes from radiation damage.
• Targeting p53, Fas, and Bcl-2 pathways could be crucial for managing radiation injury and promoting tissue repair.